281:
1268:
29:
198:
175:
306:
and in 2017, it further diluted 3.01% stake to
Capital International. Though, by May 2020, ChrysCapital bought back Capital International's stake. Currently, the Chudgar family, owns 83.85% stake in the company, with 10.13% being held by Temasek Holdings, and 6.02% by ChrysCapital.
272:. It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico. In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India. Its market presence is in more than 100+ countries.
510:'s Fawdon plant in the UK for manufacturing generic effervescent medicines. The plant was acquired in 2015 after Sanofi closed the facility. This is the fifth manufacturing location for Accord in the country after Harrow, Barnstaple, Haverhill, and Didcot.
1036:
377:
in Europe and was certified as EU GMP-compliant in April 2007, becoming the first company in India to receive such certification. In 2015, the company launched its first biosimilar product, Filgrastim in Europe, to treat patients with advanced
425:-headquartered Accord Healthcare is a fully-owned subsidiary of Intas Pharmaceuticals, which deals with large-scale generic pharmaceuticals across Europe and North America markets. It also manages an American
1086:
1313:
785:
631:
1318:
895:
1113:
1232:
351:. Later in 2012–13, the subsidiary was merged with the parent company Intas Pharmaceuticals Limited. This division is involved in development and manufacturing of
1139:
840:
1293:
1283:
1184:
1061:
650:
759:
1303:
1308:
1288:
523:
1323:
533:, Intas plant in Sanand was found to be in violation of multiple laboratory practices and protocols, as revealed in a report from January 2023.
957:
924:
347:
In 2000, an independent biotechnology division of Intas
Pharmaceuticals was incorporated as Intas Biopharmaceuticals by Urmish Chudgar, a
269:
811:
1157:
553:
438:
265:
866:
1216:
530:
367:
732:"Intas Pharmaceuticals Limited: Long-term rating upgraded to [ICRA]AA+ (Stable); shortterm rating reaffirmed"
280:
298:
In 2013, ChrysCapital acquired 16.14% stake in the company, and in 2015, ChrysCapital subsequently sold 10.13% to
394:
1037:"Intas buys Teva's UK & Ireland assets for $ 764 million to break into global top 20 generic players club"
578:
573:
558:
253:
1298:
873:
568:
434:
430:
360:
158:
487:
455:
28:
522:
received show-cause notices for selling anti-diabetic medicine without seeking price approval from
900:
563:
56:
983:
731:
932:
602:
261:
494:
603 million. The deal included a portfolio of generic medicines and a manufacturing plant in
303:
1185:"Mankind Pharma, Intas found selling diabetes drug 'without nod', to get show cause notice"
1009:
409:
and several other national health authorities for its manufacturing facility and products.
1267:
356:
330:) with capacity to manufacture and export more than 1 billion solid dosages and 5 million
52:
42:
310:
As of March 2021, the company is operating 19 manufacturing facilities globally - 13 in
519:
491:
459:
154:
1158:"500 jobs to be created by Accord Healthcare at its new Fawdon Pharmaceutical Factory"
1277:
379:
292:
736:
390:
348:
150:
1087:"Intas to acquire UK & Ireland generics businesses from Teva for £603 million"
700:
383:
331:
544:
manufactured by Intas was not a functional substitute for the brand name drug.
541:
495:
374:
371:
352:
222:
190:
146:
936:
730:
Dewan, Shamsher; Shah, Kinjal; Jain, Gaurav; Gupta, Vanshika (19 July 2021).
1211:
327:
299:
257:
92:
1140:"Intas puts the fizz back into ex-Sanofi plant with generic effervescents"
841:"Intas Pharmaceuticals: Intas Pharma merges group companies, subsidiaries"
675:
1189:
537:
284:
786:"ChrysCapital backs Intas again, buys 3%, valuation hits $ 4.3 billion"
536:
Testing conducted on behalf of the
American military by the laboratory
483:
479:
463:
406:
162:
96:
370:) audit in December 2006 to seek approval for a clinical trial of its
507:
422:
319:
1233:"The Pentagon Wants to Root Out Shoddy Drugs. The FDA Is In Its Way"
426:
389:
Apart from EU GMP certification, the company has approvals from MCC
478:
In 2017, the company's Accord
Healthcare announced acquisition of
402:
398:
323:
322:. The company has set up a new manufacturing facility in PHARMEZ (
311:
279:
295:
pharmacist
Hasmukh Chudgar in 1977 and was incorporated in 1985.
812:"Analyst Report - Intas Pharmaceuticals Limited, March 11, 2021"
1261:
467:
236:
651:"Intas Pharma may offload 10% to raise Rs200 cr from market"
315:
1114:"Intas Pharma In No Hurry To List, Says MD Binish Chudgar"
1062:"Intas Pharmaceuticals Completes Deal to Acquire Actavis"
760:"Temasek pumps more than Rs4,600 crore into India in Q1"
632:"Chudgars of Intas: A family that dreams big together"
506:
In 2018, Intas' subsidiary Accord
Healthcare reopened
958:"Intas Pharmaceuticals launches biosimilar in Europe"
867:"Global pharma looks to India: Prospects for growth"
529:
In
December 2022, upon compliance inspection by the
343:
231:
221:
211:
188:
169:
142:
116:
106:
88:
80:
62:
48:
38:
1035:Dandekar, Vikas; Barman, Arijit (6 October 2016).
630:Dandekar, Vikas; Barman, Arijit (7 October 2016).
984:"Intas's Growth Driver : Biopharmaceuticals"
1231:Edney, Anna; Griffin, Riley (5 December 2023).
33:Headquarters of Intas Biopharmaceuticals (IBPL)
810:Modi, Krunal; Sharma, Ranjan (11 March 2021).
437:. As of 2018, the company has approval for 89
8:
1314:Pharmaceutical companies established in 1977
925:"Intas Pharma launches biosimilar in Europe"
21:
16:Indian multinational pharmaceutical company
1319:Manufacturing companies based in Ahmedabad
1266:
1212:"Compliance Record: Intas Pharmaceuticals"
896:"Intas mfg unit gets EU-GMP certification"
27:
20:
597:
595:
593:
524:National Pharmaceutical Pricing Authority
518:In December 2020, the company along with
441:and is selling 255 dosing presentations.
1016:. Generic Supplement 2018. 9 August 2018
676:"Financials – Intas Pharmaceuticals Ltd"
649:Shrivastava, Bhuma (29 September 2007).
625:
623:
589:
450:Teva Pharmaceuticals (UK & Ireland)
1010:"Accord Healthcare Inc August 9, 2018"
454:In 2016, Intas acquired the assets of
7:
1183:Chandna, Himani (31 December 2020).
725:
723:
721:
382:and immune system disorders such as
1294:Pharmaceutical companies of Gujarat
923:Subbu, Ramnath (23 February 2015).
865:Shetty, Sujay; Vishwakarma, Nisha.
1284:Pharmaceutical industry of Gujarat
1112:Babla, Shraddha (7 October 2016).
14:
1304:Pharmaceutical companies of India
1138:Flora Southey (31 January 2018).
839:Unnithan, Chitra (18 June 2012).
784:Chanchani, Madhav (2 June 2020).
439:Abbreviated New Drug Applications
366:The company underwent an EU GMP (
1309:Biotechnology companies of India
1289:Pharmaceutical industry of India
554:Pharmaceutical industry in India
197:
196:
174:
173:
603:"Intas Pharmaceuticals Limited"
1324:1977 establishments in Gujarat
758:Sarkar, Pooja (10 July 2015).
701:"Hasmukh Chudgar & family"
488:Teva Pharmaceutical Industries
287:tablets manufactured by Intas.
260:. It is a producer of generic
1:
490:, for an enterprise value of
291:The company was founded by a
250:Intas Pharmaceuticals Limited
207:(US$ 290 million) (FY23)
184:(US$ 2.4 billion) (FY23)
1217:Food and Drug Administration
501:
125:(Vice Chairman and Joint MD)
368:Good Manufacturing Practice
252:is an Indian multinational
68:; 47 years ago
1340:
474:Actavis (UK & Ireland)
266:contract clinical research
1162:Invest North East England
680:Intas Pharmaceuticals Ltd
429:unit which is located at
26:
395:Gulf Cooperation Council
579:Century Pharmaceuticals
574:Alembic Pharmaceuticals
559:Torrent Pharmaceuticals
1144:Outsourcing-Pharma.com
874:PricewaterhouseCoopers
569:Cadila Pharmaceuticals
540:revealed that generic
431:Research Triangle Park
288:
254:pharmaceutical company
159:over-the-counter drugs
962:The Financial Express
502:Sanofi's Fawdon Plant
361:monoclonal antibodies
283:
22:Intas Pharmaceuticals
456:Teva Pharmaceuticals
147:Pharmaceutical drugs
484:Actavis Ireland Ltd
213:Number of employees
23:
1041:The Economic Times
901:The Economic Times
845:The Times of India
790:The Times of India
636:The Economic Times
564:Zydus Lifesciences
355:products based on
289:
217:22093+ (2024)
131:(Joint MD and CEO)
57:Biopharmaceuticals
1164:. 25 January 2018
990:. 23 January 2015
418:Accord Healthcare
262:therapeutic drugs
256:headquartered in
247:
246:
227:Accord Healthcare
1331:
1270:
1265:
1264:
1262:Official website
1248:
1247:
1245:
1243:
1228:
1222:
1221:
1208:
1202:
1201:
1199:
1197:
1180:
1174:
1173:
1171:
1169:
1154:
1148:
1147:
1135:
1129:
1128:
1126:
1124:
1109:
1103:
1102:
1100:
1098:
1093:. 5 October 2016
1083:
1077:
1076:
1074:
1072:
1058:
1052:
1051:
1049:
1047:
1032:
1026:
1025:
1023:
1021:
1006:
1000:
999:
997:
995:
980:
974:
973:
971:
969:
954:
948:
947:
945:
943:
920:
914:
913:
911:
909:
892:
886:
885:
883:
881:
871:
862:
856:
855:
853:
851:
836:
830:
829:
827:
825:
816:
807:
801:
800:
798:
796:
781:
775:
774:
772:
770:
755:
749:
748:
746:
744:
727:
716:
715:
713:
711:
697:
691:
690:
688:
686:
672:
666:
665:
663:
661:
646:
640:
639:
627:
618:
617:
615:
613:
599:
304:Temasek Holdings
243:
240:
238:
206:
204:
200:
199:
183:
181:
177:
176:
138:
132:
126:
76:
74:
69:
31:
24:
1339:
1338:
1334:
1333:
1332:
1330:
1329:
1328:
1274:
1273:
1260:
1259:
1256:
1251:
1241:
1239:
1230:
1229:
1225:
1210:
1209:
1205:
1195:
1193:
1182:
1181:
1177:
1167:
1165:
1156:
1155:
1151:
1137:
1136:
1132:
1122:
1120:
1111:
1110:
1106:
1096:
1094:
1085:
1084:
1080:
1070:
1068:
1060:
1059:
1055:
1045:
1043:
1034:
1033:
1029:
1019:
1017:
1008:
1007:
1003:
993:
991:
982:
981:
977:
967:
965:
956:
955:
951:
941:
939:
922:
921:
917:
907:
905:
894:
893:
889:
879:
877:
869:
864:
863:
859:
849:
847:
838:
837:
833:
823:
821:
814:
809:
808:
804:
794:
792:
783:
782:
778:
768:
766:
757:
756:
752:
742:
740:
729:
728:
719:
709:
707:
699:
698:
694:
684:
682:
674:
673:
669:
659:
657:
648:
647:
643:
629:
628:
621:
611:
609:
601:
600:
591:
587:
550:
516:
504:
480:Actavis UK Ltd.
476:
452:
447:
420:
415:
357:recombinant DNA
345:
340:
278:
264:and engaged in
235:
214:
202:
201:
193:
179:
178:
155:antiviral drugs
136:
135:
134:Urmish Chudgar
133:
130:
129:
128:Nimish Chudgar
127:
124:
123:
122:Binish Chudgar
119:
109:
102:
84:Hasmukh Chudgar
72:
70:
67:
55:
53:Pharmaceuticals
34:
17:
12:
11:
5:
1337:
1335:
1327:
1326:
1321:
1316:
1311:
1306:
1301:
1296:
1291:
1286:
1276:
1275:
1272:
1271:
1255:
1254:External links
1252:
1250:
1249:
1223:
1203:
1175:
1149:
1130:
1118:BloombergQuint
1104:
1078:
1053:
1027:
1014:Pharmacy Times
1001:
975:
964:. 6 March 2015
949:
915:
904:. 13 June 2007
887:
857:
831:
802:
776:
750:
717:
692:
667:
641:
619:
588:
586:
583:
582:
581:
576:
571:
566:
561:
556:
549:
546:
520:Mankind Pharma
515:
512:
503:
500:
475:
472:
451:
448:
446:
443:
419:
416:
414:
411:
344:
341:
339:
336:
277:
274:
245:
244:
233:
229:
228:
225:
219:
218:
215:
212:
209:
208:
194:
189:
186:
185:
171:
167:
166:
144:
140:
139:
120:
117:
114:
113:
110:
107:
104:
103:
100:
90:
86:
85:
82:
78:
77:
64:
60:
59:
50:
46:
45:
40:
36:
35:
32:
15:
13:
10:
9:
6:
4:
3:
2:
1336:
1325:
1322:
1320:
1317:
1315:
1312:
1310:
1307:
1305:
1302:
1300:
1299:Indian brands
1297:
1295:
1292:
1290:
1287:
1285:
1282:
1281:
1279:
1269:
1263:
1258:
1257:
1253:
1238:
1237:Bloomberg.com
1234:
1227:
1224:
1219:
1218:
1213:
1207:
1204:
1192:
1191:
1186:
1179:
1176:
1163:
1159:
1153:
1150:
1145:
1141:
1134:
1131:
1119:
1115:
1108:
1105:
1092:
1091:@businessline
1088:
1082:
1079:
1067:
1063:
1057:
1054:
1042:
1038:
1031:
1028:
1015:
1011:
1005:
1002:
989:
985:
979:
976:
963:
959:
953:
950:
938:
934:
930:
926:
919:
916:
903:
902:
897:
891:
888:
875:
868:
861:
858:
846:
842:
835:
832:
820:
813:
806:
803:
791:
787:
780:
777:
765:
761:
754:
751:
739:
738:
733:
726:
724:
722:
718:
706:
702:
696:
693:
681:
677:
671:
668:
656:
652:
645:
642:
637:
633:
626:
624:
620:
608:
604:
598:
596:
594:
590:
584:
580:
577:
575:
572:
570:
567:
565:
562:
560:
557:
555:
552:
551:
547:
545:
543:
539:
534:
532:
527:
525:
521:
514:Controversies
513:
511:
509:
499:
497:
493:
489:
485:
481:
473:
471:
470:764 million.
469:
465:
461:
457:
449:
444:
442:
440:
436:
432:
428:
424:
417:
412:
410:
408:
404:
400:
396:
392:
387:
385:
381:
380:HIV infection
376:
373:
369:
364:
362:
358:
354:
350:
342:
337:
335:
333:
329:
325:
321:
317:
313:
308:
305:
301:
296:
294:
286:
282:
275:
273:
271:
270:manufacturing
267:
263:
259:
255:
251:
242:
234:
230:
226:
224:
220:
216:
210:
195:
192:
187:
172:
168:
164:
160:
156:
152:
151:generic drugs
148:
145:
141:
121:
115:
111:
105:
98:
94:
91:
87:
83:
79:
65:
61:
58:
54:
51:
47:
44:
41:
37:
30:
25:
19:
1240:. Retrieved
1236:
1226:
1215:
1206:
1194:. Retrieved
1188:
1178:
1166:. Retrieved
1161:
1152:
1143:
1133:
1121:. Retrieved
1117:
1107:
1095:. Retrieved
1090:
1081:
1069:. Retrieved
1066:Moneycontrol
1065:
1056:
1044:. Retrieved
1040:
1030:
1018:. Retrieved
1013:
1004:
992:. Retrieved
987:
978:
966:. Retrieved
961:
952:
940:. Retrieved
928:
918:
906:. Retrieved
899:
890:
878:. Retrieved
876:. p. 19
860:
848:. Retrieved
844:
834:
822:. Retrieved
819:CARE Ratings
818:
805:
793:. Retrieved
789:
779:
767:. Retrieved
763:
753:
741:. Retrieved
737:ICRA Limited
735:
708:. Retrieved
704:
695:
683:. Retrieved
679:
670:
658:. Retrieved
654:
644:
635:
610:. Retrieved
606:
535:
528:
517:
505:
477:
453:
445:Acquisitions
421:
413:Subsidiaries
391:South Africa
388:
365:
349:hematologist
346:
309:
297:
290:
249:
248:
239:.intaspharma
223:Subsidiaries
182:20,079 crore
89:Headquarters
39:Company type
18:
384:neutropenia
332:injectables
318:, and 1 in
314:, 5 in the
205:2,422 crore
108:Area served
1278:Categories
1242:5 December
988:NCK Pharma
660:9 February
612:4 December
585:References
542:tacrolimus
496:Barnstaple
375:Filgrastim
372:biosimilar
353:biosimilar
191:Net income
137:(Joint MD)
118:Key people
1196:3 October
1168:3 October
1123:3 October
1020:3 October
994:3 October
968:3 October
942:3 October
937:0971-751X
929:The Hindu
908:3 October
880:3 October
850:3 October
824:3 October
795:3 October
769:3 October
743:3 October
710:3 October
685:1 January
338:Divisions
328:Ahmedabad
300:Singapore
258:Ahmedabad
112:Worldwide
93:Ahmedabad
1190:ThePrint
548:See also
538:Valisure
285:Etizolam
163:vaccines
143:Products
49:Industry
464:Ireland
458:in the
427:R&D
407:Belarus
397:(GCC),
326:, near
302:-based
276:History
232:Website
170:Revenue
97:Gujarat
81:Founder
71: (
63:Founded
43:Private
1097:4 July
935:
705:Forbes
508:Sanofi
435:Durham
423:London
320:Mexico
1071:8 May
1046:8 May
870:(PDF)
815:(PDF)
486:from
403:Yemen
399:Syria
324:Bavla
312:India
101:India
1244:2023
1198:2021
1170:2021
1125:2021
1099:2021
1073:2020
1048:2020
1022:2021
996:2021
970:2021
944:2021
933:ISSN
910:2021
882:2021
852:2021
826:2021
797:2021
771:2021
764:mint
745:2021
712:2021
687:2022
662:2023
655:mint
614:2023
607:ICRA
482:and
468:US$
466:for
462:and
359:and
293:Jain
268:and
241:.com
73:1977
66:1977
531:FDA
237:www
1280::
1235:.
1214:.
1187:.
1160:.
1142:.
1116:.
1089:.
1064:.
1039:.
1012:.
986:.
960:.
931:.
927:.
898:.
872:.
843:.
817:.
788:.
762:.
734:.
720:^
703:.
678:.
653:.
634:.
622:^
605:.
592:^
526:.
498:.
460:UK
433:,
405:,
401:,
393:,
386:.
363:.
334:.
316:UK
161:,
157:,
153:,
149:,
99:,
95:,
1246:.
1220:.
1200:.
1172:.
1146:.
1127:.
1101:.
1075:.
1050:.
1024:.
998:.
972:.
946:.
912:.
884:.
854:.
828:.
799:.
773:.
747:.
714:.
689:.
664:.
638:.
616:.
492:£
203:₹
180:₹
165:,
75:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
